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CATECHOL-O-METHYL TRANSFERASE IN SKIN OF PATIENTS
WITH ATOPIC DERMATITIS*
JALAL BAMSHAD, MD., C.R.C.P.(c)
In recent years possible disturbances of
catecholamine metabolism in atopic dermatitis
has been suggested to be due to association of
this disease with some of the signs and symp-
toms of abnormal metabolism of these amines
in the skin (1—11).
Paradoxical response of skin of patients with
atopic dermatitis to intradermal injection of
acetylcholine (12) and normal response by
prctrcating skin iontophoretically with guane-
thidinc (13) supports the above hypothesis. It
also has been shown that when norepincphrine
is introduced into the skin iontophoretically it
remains longer in the skin of patients with
atopic dermatitis than in patients with other
skin diseases (14).
If catecholamines stay in the skin of patients
with atopic dermatitis as an active agent
longer than in normal skin, there could be a
defect in one or some of the following mech-
anisms.
1. Disturbances in the mnin pathway of me-
tabolism of catecholamincs due to defi-
ciency of catechol-O-Methyl Transfcrase
(COMT).
2. Disturbances in rebinding of catechol-
amines with the granulated vesicles of the
sympathetic nerve endings (15, 16).
3. Increased secretion of these amincs at the
nerve endings.
4. Decreased absorption of these amines by
the capillaries.
Since COMT is present in skin (17) (Table
I) and is involved in the main pathway of the
metabolism of catccholamines (18, 19), absence
or low activity of this enzyme may result in
an accumulation of physiologically active
amines in the skin and this in turn might cause
an abnormal vascular reaction in the skin sim-
ilar to what is observed in the skin of patients
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with atopic dermatitis. This paper reports the
activity of this enzyme in the skin of patients
with this disease.
MATERIAL AND METHODS
Biopsy specimens were obtained from involved
and adjacent non-involved areas of skin of patients
with known atopic dermatitis and normal skin of
individuals withoot dermatitis and assayed for
COMT by the method of Axelrod et al. (20, 21).
Tn this procedure the amount of C14 metanephrine
formed from methylCH 8-Adenosylmethionine(8-AMe) and unlabeled cpinephrine in the pres-
ence of skin powder is measured.
After biopsy and dissection of fat, the skin was
brought to and kept below freezing with dry ice
and pulverized. This powder was used directly in
the assay.
Pulverized skin was incubated at 37° for an hour
in 10 ml glass stoppered centrifuge tubes. Each
reaction mixture contained 300 tel 0.2 M sodium
phosphate buffer pH (7.8), 25 pl 0.5 M magnesium
chloride, 100 pg L-epinephrine bitartrate in 50 pl
water and 0.01 pe methyl C'5 8-AMe in 25 pl
water. The C'4 8-AMe had an activity of 53 inc
per mmole. At the end of the incubation period,
0.5 ml of 0.5M potassium borate buffer (pH 10)
and 6 ml of a mixture of toluene-isamyl alcohol
(3:2) were added to the reaction mixture and the
tubes were shaken for 15 minutes. A 4 ml aliquot
of the organic phase was mixed with 1 ml ethanol
and 10 ml of toluene Liquiflour [containing 50 g
2,5 Diphenyloxazole (PPO) and 0.625 g P-bis-2-4
methyl-5-phenyloxazalyl benzene (POPUP)] mix-
ture. Radioactivity was measured with a liquid
scintillation spectrometer, Packard model 3324,
with an efficiency of 80% for C". Control samples
of homogenized liver were run for CUMT ac-
tivity under the samo conditions.
RESULTS
Activity of COMT in involved and clear
areas of skin of patients with atopio dermatitis
was compared. It was found that activity of
the enzyme in involved areas of skin of 7 out of
10 patients was greater than in clear areas of
the skin of the same patients and skin of nor-
mal individuals (Table I and II). The enzyme
activity was also compared with the activity
of the enzyme in skin of patients with derma-
titis of non-atopic type (Table III). It seemed
that CUMT activity in involved areas of the
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TABLE I
Activity of catechol-0-methyl lransf erase in normal skin
Number Age Sex Site Total count!mm/mg skin
Control count!
min/ mg skin
Net COMT/
mm/mg skin
1
2
3
4
5
6
7
8
9
10
42
75
40
47
64
56
65
54
47
41
Male
Female
Female
Male
Male
Female
Male
Female
Female
Female
Abdomen
Abdomen
Breast
Abdomen
Hand
Neck
Abdomen
Abdomen
Chest
Abdomen
181
152
147
100
150
124
161
123
125
130
21
37
39
61
27
53
34
37
42
26
160
115
108
39
123
71
127
86
83
104
Average count/mm/mg skin 139 38 101
TABLE II
Activity of catechol-0methyl Lransf erase in skin of
patients with atopic dermatitis
No. Sex
Left arm
Left arm
Left forearm
Left forearm
* Right pop-
leteal fossa
Left arm
f Right thenar
Left arm
Left arm
Left arm
Average for 1 mg skin 156 273
* Involved from right popleteal fossa.
Involved from right thenar.
skin of two groups of the patients, one with
and one without atopic dermatitis, is higher
than clear areas of skin of the same patients,
and as far as COMT is concerned, involved
areas of the skin of patients with atopic der-
matitis is not different from involved areas of
the skin of patients with other types of derma-
titis.
The greater activity of the enzyme in in-
volved areas of skin of patients with atopic
dermatitis shows that this pathway of metab-
olism of catecholamines in skin of patients with
TABLE III
Activity of catechol -0-methyl transf erase in skin of
patient with non-atopic dermatitis
From paper on Catechol-O-Methyl Transferase
in Cutaneous Inflammation.
No. Age Sex Site
Involved area
(count/mgnl
skin/mm)
Clear area
(count/mgm
skin/mm)
1
2
3
4
5
6
7
8
9
10
76
30
66
66
39
22
70
62
51
26
F
F
M
M
M
F
F
F
F
F
Arm
Arm
Arm
Arm
Arm
Arm
Arm
Arm
Arm
Arm
282
212
107
344
294
438
610
407
273
232
41
80
46
48
43
281
135
73
186
[20
Average count for 1 mg 320 105
atopic dermatitis is the same as in the skin of
patients with other types of dermatitis. If there
was an accumulation of catecholamines because
of a defect in this pathway only, the enzyme
would have been less active in involved areas
than clear areas of skin of patients with atopic
dermatitis.
SUMMARY
Activity of catechol-O-Methyl 'rransferase,
an enzyme involved in main pathway of break-
down of catecholamines, was studied in involved,
and clear adjacent areas of skin of patients
Site
1
2
3
4
5
6
7
8
9
10
Age
24
27
37
26
10
22
13
10
265
F
M
F
F
F
F
F
F
F
M
Clear
(count!
mgm skin!
mm)
44
182
307
120
153
395
88
66
115
86
Involved
(count!
mgrn skin/
mm)
108
264
238
322
338
223
54
405
361
413
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with atopic dermatitis and non-atopie derma-
titis. It was found that COMT activity was
greater in involved areas of both diseases than
in their respective adjacent normal skin areas.
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